-
Medical professional liability studies most often use aggregated data across all physicians in a specialty and lack data on those who were not sued.
-
The introduction of transcatheter aortic valve replacement (TAVR) has been a transformative step in the treatment of severe aortic stenosis. Patients who are ineligible or very high-risk for open surgery are now routinely treated with this less-invasive option.
-
-
-
Percutaneous coronary intervention (PCI) is performed in more than 600,000 patients annually in the United States, and women make up approximately one-third of this population.
-
This paper reviews drug therapy in patients with atrial fibrillation in the Medicare population. The author extracted a 5% sample of Medicare beneficiaries who were enrolled in Medicare Part D.
-
-
This paper details the result of a population-based cohort study of all Ontario, Canada, residents older than 66 years of age who began warfarin therapy for atrial fibrillation over an 11-year period.
-
Angioedema is an infrequent, but serious, adverse event from drug therapy. Drugs that affect the renin-angiotensin-aldosterone system have been linked to angioedema, but the relative frequency of this complication with these drugs is poorly understood.
-
As our population ages and outcomes from revascularization also improve, more elderly patients are being referred for coronary artery bypass graft surgery (CABG) and for percutaneous coronary intervention (PCI).